|
Lisinopril is used for treating high blood pressure alone or with other medicines. Lisinopril 20 mg tabletten pzn kow (3.80 p.o.) or placebo twice daily 4 wk (n = 34). Baseline measures for the primary endpoint at week 0 were completed. Adverse events coded and analyzed by two independent raters. The primary endpoint of major cardiovascular acecomb tabletten lisinopril events was the primary outcome measure in analyses. Secondary endpoints included major adverse events, and the changes in adverse events, and change cardiovascular biomarkers. RESULTS: During the 5-wk run-in period there were no serious adverse events in either group. There were four cardiovascular adverse events. There were no significant changes in the primary or online pharmacy uk amoxicillin secondary endpoint after treatment (p =.24 and p.21, respectively). The rate of change was 11% in the control group and 10% in the treatment group (p =.09). The rate ratio of change in cardiovascular biomarkers was 2.5 (95% CI 1.7-3.5) in tabletten lisinopril stada the control group and 2.1 (95% CI 1.1-4.5) in the treatment group. All adverse events were similar in the two treatment group |